Cerebain Biotech (OTCBB: CBBT) today announced that the company has engaged biotech industry veteran Miriam Weber Miller to serve on the executive team, as corporate vice president, reporting to CEO Eric Clemons. The appointment comes as Cerebain readies itself for clinical trials in Europe for the evaluation of a new approach to Alzheimer’s treatment. Weber Miller will work cross-functionally, driving business development, and growth strategies communication and investor relations. She will also serve as a corporate spokesperson.
Help employers find you! Check out all the jobs and post your resume.
